Glassman Wealth Services’s Milestone Scientific MLSS Stock Holding History

Glassman Wealth Services’s Portfolio MLSS Stock Details MLSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1	Closed	–	–	1878
2022 Q1	$0	Buy	+1	New	+$1	﹤0.01%	1825

Other funds holding MLSS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

swisspartners Vaduz, Liechtenstein $78.4M AUM 9.82% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Castleview Partners Dallas, Texas $228M AUM 19.85% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Glassman Wealth Services's MLSS Position: Q2 2022 in Review

Glassman Wealth Services sold out of Milestone Scientific (MLSS) in Q2 2022, closing a stake of 1 share.

Glassman Wealth Services first reported a position in MLSS in Q1 2022 and held it in 1 quarter. The position peaked at $0 in Q1 2022. 39 funds tracked by Wall St. Rank hold MLSS as of Q2 2022.

Glassman Wealth Services reported no remaining Milestone Scientific position as of Q2 2022 after selling out during the quarter.
Glassman Wealth Services sold 1 Milestone Scientific share in Q2 2022.
Glassman Wealth Services first reported a position in Milestone Scientific in Q1 2022 and held it in 1 quarter.
Glassman Wealth Services's Milestone Scientific position peaked at $0 in Q1 2022.
39 funds tracked by Wall St. Rank held Milestone Scientific as of Q2 2022.

Based on Glassman Wealth Services's 13F filing for Q2 2022, filed 4 Aug 2022.